0Y6X.LSE Medtronic PLC

Healthcare Commercial Services & Supplies London Exchange
- USD
Market cap
-
P/E
26.5x
P/B
-
ROE
11.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jul 2026.

Is 0Y6X.LSE undervalued?

Graham number

The Graham number of Medtronic PLC cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Medtronic PLC fundamental analysis

No fundamental analysis for Medtronic PLC yet.

Medtronic PLC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablati…

Full company profile